L
LEGEND BIOTECH CORP
NASDAQ: LEGN (Legend Biotech Corporation)
最近更新时间: 2小时之前34.08
0.06 (0.18%)
前收盘价格 | 34.02 |
收盘价格 | 34.35 |
成交量 | 1,589,842 |
平均成交量 (3个月) | 1,487,543 |
市值 | 6,251,976,192 |
预期市盈率 (P/E Forward) | 1.00 |
价格/销量 (P/S) | 11.95 |
股市价格/股市净资产 (P/B) | 5.60 |
52周波幅 | |
利润日期 | 10 Mar 2025 - 14 Mar 2025 |
营业毛利率 | -66.92% |
营业利益率 (TTM) | -43.92% |
稀释每股收益 (EPS TTM) | -1.92 |
季度收入增长率 (YOY) | 66.90% |
总债务/股东权益 (D/E MRQ) | 31.05% |
流动比率 (MRQ) | 4.98 |
营业现金流 (OCF TTM) | -157.60 M |
杠杆自由现金流 (LFCF TTM) | -120.41 M |
资产报酬率 (ROA TTM) | -12.28% |
股东权益报酬率 (ROE TTM) | -28.35% |
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 混合的 | 混合的 |
Biotechnology (全球的) | 混合的 | 混合的 | |
股票 | Legend Biotech Corporation | 看涨 | 看跌 |
AIStockmoo 评分
1.6
分析师共识 | 5.0 |
内部交易活动 | NA |
价格波动 | 4.0 |
技术平均移动指标 | 0.0 |
技术振荡指标 | -2.5 |
平均 | 1.63 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue. |
|
部门 | Healthcare |
行业 | Biotechnology |
内部持股比例 | 1.31% |
机构持股比例 | 51.21% |
52周波幅 | ||
目标价格波幅 | ||
高 | 86.00 (RBC Capital, 152.35%) | 购买 |
86.00 (Redburn Atlantic, 152.35%) | 购买 | |
中 | 84.50 (147.95%) | |
低 | 73.00 (HC Wainwright & Co., 114.20%) | 购买 |
平均值 | 82.00 (140.61%) | |
总计 | 4 购买 | |
平均价格@调整类型 | 42.31 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
HC Wainwright & Co. | 10 Dec 2024 | 73.00 (114.20%) | 购买 | 37.90 |
13 Nov 2024 | 73.00 (114.20%) | 购买 | 39.35 | |
Cantor Fitzgerald | 09 Dec 2024 | 83.00 (143.54%) | 购买 | 41.63 |
RBC Capital | 09 Dec 2024 | 86.00 (152.35%) | 购买 | 41.63 |
29 Oct 2024 | 86.00 (152.35%) | 购买 | 45.46 | |
Redburn Atlantic | 08 Oct 2024 | 86.00 (152.35%) | 购买 | 48.06 |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合